- $2.88bn
- $9.25bn
- $1.52bn
Brief: FSK Prices Public Offering Of $600 Million 6.125% Unsecured Notes Due 2030
Brief: FSK Prices Public Offering Of $600 Million 6.875% Unsecured Notes Due 2029
U.S. RESEARCH ROUNDUP-Autozone, Constellation Energy, Sterling Infrastructure
Brief: Fsk Completes Public Offering Of $400 Million
Brief: FSK Prices Public Offering Of $400 Mln 7.875% Unsecured Notes Due 2029
Brief: FSK Prices Public Offering Of $400 Mln 7.875% Unsecured Notes Due 2029
Brief: FS KKR Capital Q3 EPS USD 0.95
Brief: FS KKR Capital Corp. Announces First Quarter 2023 Results, Declares Second Quarter 2023 Distribution Of $0.70 Per Share
SVB debacle sparks rush to defensive options on fears of contagion
Brief: FS Kkr Capital Corp. Reports Fourth Quarter And Full Year 2022 Results
Dial Square Invest. - Interim Accounts
Brief: FS KKR Capital Corp Reports Q3 Loss Per Share Of $1.21
U.S. RESEARCH ROUNDUP-Abiomed, McDonald's, S&P Global
NYSE ORDER IMBALANCE 183132.0 SHARES ON SELL SIDE
U.S. RESEARCH ROUNDUP-Organon & Co, Signify Health, Whitehorse Finance
U.S. RESEARCH ROUNDUP- Axon Enterprise, Berkeley Lights, Minerva Surgical
Brief: FS KKR Capital Reports Q2 Adjusted Loss Per Share $0.92
NYSE ORDER IMBALANCE 50590.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 118368.0 SHARES ON BUY SIDE